首页> 外文期刊>薬物動態 >Pharmacokinetic Studies of [~14C]Urea (1); Absorption, Distribution, Metabolism and Excretion after Single Administration of [~14C] Urea in Fasted Rats
【24h】

Pharmacokinetic Studies of [~14C]Urea (1); Absorption, Distribution, Metabolism and Excretion after Single Administration of [~14C] Urea in Fasted Rats

机译:[〜14c]尿素的药代动力学研究(1); 禁食大鼠单一施用后施用[〜14C]尿素后的吸收,分布,代谢和排泄

获取原文
获取原文并翻译 | 示例
           

摘要

Absorption, distribution, metabolism and excretion after a single intravenous and oral administration of [~14C] urea at a dose of 2 mg/kg were investigated in fasted rats.1.Both radioactivity levels in plasma after intravenous and oral administration of [~14C] urea were decreased biphasically with t_(1/2#alpha#) of about 2.0 hr had t~(1/2#beta#) of about 3.5 hr. After oral administration, the plasma concentration reached C_max at 0.5 hr, suggesting rapid absorption of urea in the gastrointestinal tract.2.Radioactivity levels in most tissues reached C_max at 0.5 hr after oral administration, similar to that observed in the plasma. Excluding the radioactivity present in the digestive tract where [~14C] urea was administered, the concentrations in the kidney and urinary bladder were the highest in the examined tissues and were 3.2 and 2.5 times as high as that in plasma. The concentrations in other tissues were similar to , or lower than the plasma concentration. Subsequently, the concentrations in most tissues rapidly decreased in parallel with the plasma concentration.3.In plasma at 0.5 hr and 8hr after oral administration and in the urine collected for 24 hr after intravenous and oral administration, the major component of radioactivity was the unchanged drug and other metabolites were not observed. One may concluded that urea was almost not metabolized in fasted rats, considering the results of the excretion study, in which more than about 90% of dose radioactivity was excreted in urine as unchanged drug.4.Within 96 hr, 91.1%, 0.3% and 4.7% of dosed radioactivity were excreted in urine, feces and expired air after intravenous administration, and 95.1%, 1.2% and 3.5% after oral administration, respectively. The bioavailability estimated from the ratio of urinary excretion of urea after oral administration to that after intravenous administration was almost 100%.
机译:在静止的大鼠中研究了单一静脉内和口服尿布后的吸收,分布,代谢和排泄尿液剂量为2mg / kg .1。静脉内和口服给药后血浆中的放射性水平[〜14c ]尿素与约2.0小时的T_(1/2#alpha#)相比,具有约3.5小时的T〜(1/2#β#)。口服施用后,血浆浓度在0.5小时达到C_max,表明胃肠道尿素的快速吸收.2。大多数组织中的丙基达酰基在口服给药后达到C_max,类似于血浆中观察到的0.5小时。不包括在施用[〜14C]尿素的消化道中存在的放射性,肾脏和膀胱中的浓度在检查的组织中最高,血浆中的高度高3.2和2.5倍。其他组织中的浓度类似于或低于等离子体浓度。随后,大多数组织中的浓度与血浆浓度平行迅速下降。在口服给药后的0.5小时和8小时的血浆和8小时内,在静脉内和口服给药后24小时收集的尿液中,放射性的主要成分是不变的未观察到药物和其他代谢物。可以得出结论,考虑到排泄研究的结果,在尿液中,尿液的结果几乎不会在禁食大鼠中代谢,其中超过约90%的剂量放射性在尿液中排出,为未改变的药物.4。96小时,91.1%,0.3%在静脉内给药后尿液,粪便和过期空气中排出4.7%的剂量放射性,分别在口服给药后95.1%,1.2%和3.5%。口服尿素排泄比率估算的生物利用度估计静脉施用后近100%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号